Have a personal or library account? Click to login
Alternative Leprosy Treatment Using Rifampicin Ofloxacin Minocycline (ROM) Regimen – Two Case Reports Cover

Alternative Leprosy Treatment Using Rifampicin Ofloxacin Minocycline (ROM) Regimen – Two Case Reports

Serbian Journal of Dermatology and Venereology
Volume 11 (2019): Issue 3 (September 2019)
By: Yohanes Widjaja,  Khairuddin Djawad,  Saffruddin Amin,  Widyawati Djamaluddin,  Dirmawati Kadir and  Sri V. Muchtar  
Open Access
|Feb 2020

Authors

Yohanes Widjaja

Department of Dermatology And Venereology, Hasanuddin University Faculty Of Medicine, Makassar, Indonesia

Khairuddin Djawad

duddin@ymail.com

Department of Dermatology And Venereology, Hasanuddin University Faculty Of Medicine, Makassar, Indonesia

Saffruddin Amin

Department of Dermatology And Venereology, Hasanuddin University Faculty Of Medicine, Makassar, Indonesia

Widyawati Djamaluddin

Department of Dermatology And Venereology, Hasanuddin University Faculty Of Medicine, Makassar, Indonesia

Dirmawati Kadir

Department of Dermatology And Venereology, Hasanuddin University Faculty Of Medicine, Makassar, Indonesia

Sri V. Muchtar

Department of Dermatology And Venereology, Hasanuddin University Faculty Of Medicine, Makassar, Indonesia
DOI: https://doi.org/10.2478/sjdv-2019-0013 | Journal eISSN: 2406-0631
Journal RSS Feed
Language: English
Page range: 89 - 93
Submitted on: Sep 2, 2019
Accepted on: Sep 12, 2019
Published on: Feb 20, 2020
Published by: Serbian Association of Dermatovenereologists (SAD)
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Cranial Nerve Diseases,
Herpes Zoster Oticus,
Neuritis,
Signs and Symptoms,
Diagnosis,
Antiviral Agents,
Rare Diseases
Related subjects:
Medicine,
Clinical medicine,
Dermatological and veneral diseases

© 2020 Yohanes Widjaja, Khairuddin Djawad, Saffruddin Amin, Widyawati Djamaluddin, Dirmawati Kadir, Sri V. Muchtar, published by Serbian Association of Dermatovenereologists (SAD)
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 11 (2019): Issue 3 (September 2019)Next article